Digital Pathology Scanner

Pathology is a cornerstone of modern medicine, allowing healthcare professionals to diagnose diseases and disorders with unparalleled precision. For years, it has relied on glass slides and microscopes, a time-honored tradition steeped in tradition and expertise. However, the winds of change are sweeping through the field of pathology, and they carry the promise of revolutionizing the way we approach diagnostics. This transformation is encapsulated in a simple yet profound statement: The future is now, and digital pathology is, in fact, pathology itself. Digital Pathology: A New Horizon Digital pathology is a technological advancement that replaces traditional glass slides with digital images of tissue specimens. These images can be viewed, analyzed, and shared electronically, ushering in an era of rapid communication, collaboration, and accessibility that was once unimaginable. The transformation is not a distant dream but a reality that is reshaping the field: 1. Rapid Diagno...

Digital pathology is undoubtedly now the future of pathology. It is gradually transitioning from conventional microscopy to digital pathology. The flexibility, accuracy, and image analysis tools make digital pathology an attractive option. OptraSCAN a leading digital pathology solution provider offers a complete suite of products, assisting pathologists to easily implement digital pathology. Digital pathology tools such as IMAGEPath for image management systems included for viewing, storing & archiving. OptraASSAYS Image Analysis tool for AI & ML based Image Analysis Solutions. TELEPath® tool for Real-time Digital Conferencing. Artificial Intelligence and machine learning to support pathologists in their day-to-day operations. Pathologists use several techniques for enhancing tissues and samples to make specific abnormal mutations visible. Artificial Intelligence pathology could spot certain linkages which are not visible to the human eye.   Basic equipment encompass...

Digital pathology is a process of acquiring, viewing, managing, sharing, and interpreting pathology slides in a digital ecosystem. The digital image is generated when glass slides are captured with a scanning device, the captured image then can be viewed on a computer screen or mobile device. Image generated can be stored either on the system, local network, or the cloud. This eliminates the need to manually store and ship the slides.  With the support of digital pathology solutions , pathologists can now collaborate with other pathologists across the globe. They can consult, collaborate and share in real-time.  Benefits of Digital Pathology: It aims at assisting pathologists to provide better patient care;    No need for extra equipment apart from a digital scanner Prevents delay in critical patient care Pathologists can simultaneously communicate with others using Telepathology, while analyzing slides Remote consultation ...

OptraSCAN’s best & affordable digital pathology solution along with Artificial Intelligence (AI) & Machine Learning (ML)-based image analysis solution for nuclear and membrane biomarker quantification. As we look at digital pathology is transforming modern healthcare, slowly but steadily many hospitals and labs are taking cognizance of its many benefits. We have been working to make digital pathology very affordable, accessible, and easy to implement for the pathologists’ community worldwide. said Abhi Gholap, Founder & CEO, OptraSCAN. Taking such implementations will help expand the adoption of digital pathology & improve cancer research. These will definitely more institutions to collaborate and see the true rewards of AI in pathology. On-Demand desktop scanning systems are cloud-enabled. They provide ultimate flexibility for storing, archiving, and managing digital images and metadata. These are convenient for Brightfield, Fluorescence, and Confocal whole slide ...

OptraSCAN Inc offers PD-L1 biomarker & immune-oncology biomarker analysis for immune-oncology – programmed death-ligand 1 (PD-l1) expression. Programmed Cell Death Ligand-1 expression of PD-L1 is a very important cancer biomarker and it has become a critical part of patient management for immunotherapy. The targeted blockade of PD-L1 helps to restore the antitumor response. Because of the development of the combined positive score (CPS) for the evaluation of PD-L1 in solid tumors. It has been indicated that PD-L1 expression on both tumor and tumor-associated immune cells is associated with clinical outcomes. Optrascan’s Solution For Immuno - Oncology: -          -   It’s an automated image analysis (for research use) which supports the interpretation of PD-L1I HC expression on both tumor and immune cells in solid tumors. -          -=  They determines PD-L1 expression on tumor and immune cells showing par...